Funding
Funding not disclosed
Founders
Product
Problem
Neurological disorders, including brain cancer, present significant challenges due to the limitations of current treatment options. Traditional therapies often struggle to effectively target affected areas within the central nervous system (CNS) and may have limited efficacy or significant side effects. The need for more precise and effective treatments for these conditions remains unmet.
Solution
Dome Therapeutics is developing next-generation stem cell and gene therapies that leverage nanomedicine to treat CNS disorders. The company engineers patient-derived stem cells using advanced biomaterials and nanomedicine technologies to create targeted therapeutics. This approach aims to enhance the precision and efficacy of treatments for conditions like brain cancer, potentially overcoming the limitations of conventional methods.
Target Audience
The primary target audience includes patients with neurological disorders, particularly brain cancer, and the clinicians who treat them.
Features
- Nanomedicine-based delivery systems for targeted drug delivery to the CNS
- Patient-derived stem cell engineering for personalized therapeutic development
- Gene therapy approaches to modify stem cell function and enhance therapeutic effects
- Development of novel biomaterials for stem cell encapsulation and controlled release